Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

NuVasive (NUVA) News Today

NuVasive logo
Globus Medical price target raised to $80 from $55 at BofA
Globus Medical Reports Robust Q3 2024 Financial Growth
Globus Medical's EPS Tops Forecast in Q3
Barclays Keeps Their Buy Rating on Globus Medical (GMED)
Q2 2024 Globus Medical Inc Earnings Call
SMAIO Publishes its 2023 Annual Results
Q4 2023 Globus Medical Inc Earnings Call
Globus lays off Nuvasive employees after merger
SMAIO: 2023 Sales up +120% to €5.4 Million
Get NuVasive News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUVA and its competitors with MarketBeat's FREE daily newsletter.

JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.

NUVA Media Mentions By Week

NUVA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NUVA
News Sentiment

0.30

0.56

Average
Medical
News Sentiment

NUVA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NUVA Articles
This Week

0

1

NUVA Articles
Average Week

Get NuVasive News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUVA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NUVA) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners